Home
Clinical Resources Search
PQI: Liposomal Daunorubicin-Cytarabine (Vyxeos®) Management

Liposomal Daunorubicin-Cytarabine (Vyxeos®) Management

Download PQI pdf 0.22MB

Last Updated: September 2, 2023

By: Anna Howard, PharmD, BCOP

About this PQI

The purpose of this PQI is to discuss the option of using liposomal daunorubicin-cytarabine for patients with newly diagnosed therapy-related Acute Myeloid Leukemia (AML) or AML with myelodysplasiarelated changes (AML-MRC). 1

More About This PQI

PQI in Action Articles:

liposomal_VYXEOS_management pdf 1.74MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Acute Myeloid Leukemia (AML) Daunorubicin Daunorubicin/Cytarabine Vyxeos

PQI

Frequently Searched

Supported by

Liposomal Daunorubicin-Cytarabine (Vyxeos®) Management

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Venetoclax (Venclexta®) for the Treatment of Acute Myeloid Leukemia

PQI: Optimizing Venetoclax Treatment of Acute Myeloid Leukemia

PQI Podcast S5 Ep 10: Pharmacy Path & NCODA Venetoclax Resources

PQI: Gilteritinib (Xospata®) for Relapsed/Refractory Acute Myeloid Leukemia

PQI in Action: Liposomal Daunorubicin-Cytarabine (Vyxeos) Management

PQI in Action: Liposomal Daunorubicin-Cytarabine (Vyxeos) Management

PQI in Action: Liposomal Daunorubicin-Cytarabine (Vyxeos) Management

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

Treatment Support Kit: Elranatamab